ABBV vs AFL Stock Comparison
Scores Breakdown
| Metric | ABBV | AFL |
|---|---|---|
| 📈 Growth | 15/30 | 6/30 |
| 💰 Profitability | 16/20 | 10/20 |
| 🏦 Financial Health | 12/20 | 18/20 |
| 💵 Valuation | 12/20 | 14/20 |
| ⚠️ Risk (lower is better) | 6/10 | 6/10 |
| Overall Score | 59/100 | 52/100 |
Side-by-Side Summaries
| ABBV Analysis | AFL Analysis |
|---|---|
📈 Growth & Financial Trajectory8 quarters show a largely rising topline: 2024Q1 to 2026Q1 Revenues rise from about $12.31B to $15.00B (+≈22%). Net income attributable to parent falls from ~$1.29B to ~$0.70B, though peaks around ~$1.86B in 2025Q2–Q3, with 2025Q4 at ~$1.82B. The trend is mixed: topline strength persists, but bottom-line profitability weakens into 2026Q1. 💰 Margins & Cash FlowGross margins remain high, broadly ~70–79%, reflecting a durable product mix. Operating leverage remains healthy as volumes expand. Net cash flow from operating activities stays robust, typically around $5.1B–$5.3B per quarter; investing activity is negative (capex/activity), and financing flows cause periodic swings. 🛡️ Balance Sheet & LiquidityTotal assets hover near the mid-to-upper hundreds of billions with liabilities that verge on or exceed assets in some periods, and equity attributable to the parent is often negative (reflecting buybacks). The firm generates solid operating cash flow that supports liquidity despite leverage. Long-term debt runs in the mid-$60B range in recent periods, with current liabilities ~$39–$44B. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryThe eight quarterly results show a mixed growth path. Start: revenues of $5.138B in 2024 Q2 and end: $4.346B in 2026 Q1, a decline of about 15%. Net income moved from $1.755B in 2024 Q2 to $1.019B in 2026 Q1, down roughly 42%. Notable quarter-to-quarter swings include a robust Q4 2024 and steady early-2025 quarters, but the overall trend is inconsistent, with revenue occasionally bouncing on seasonal/one-offs while earnings remain volatile. Operating income remained strong in several periods (around $3.0–$3.4B on mid-single to low-double-digit revenue), suggesting earnings power when volume picks up, but not a clear, sustained growth trajectory. 💰 Margins & Cash FlowMargins vary meaningfully by quarter; reported operating income margins range widely, reflecting unusual items and mix. Net cash from operating activities was solid in several quarters (e.g., $589M in 2025 Q1 and $968M in 2026 Q1) but softer in others (e.g., $315M in 2025 Q4). Investing and financing activities can create negative free cash flow in some periods, yielding an uneven cash flow signal despite positive operating cash in many quarters. 🛡️ Balance Sheet & LiquidityAssets typically sit around $116–$122B, with Liabilities in the $86–$93B range and Equity near $26–$30B, indicating reasonable leverage and strong liquidity. The structure supports resilience across varying earnings seasons, though reported items occasionally show anomalies in current liabilities. ⚠️ Key Drivers & Risks
|